Cancellous sponge market seen reaching $8.76 billion by 2030

The Business Research Company says the cancellous sponge market will grow from $6.65 billion in 2025 to $7.04 billion in 2026, with orthopedic surgery demand and new biomaterials helping drive the forecast. North America led the market in 2025, while the report highlights growth opportunities in dental, plastic surgery and minimally invasive procedures.

Why it matters: - Cancellous sponges support bone repair and regeneration in orthopedic and related surgeries. - The market is projected to keep expanding as surgical volumes rise and providers look for better bone grafting materials. - Growth in synthetic, composite, bioactive and regenerative products could broaden use beyond traditional wound care.

What happened: - The Business Research Company published its "Cancellous Sponge Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The report values the market at $6.65 billion in 2025 and $7.04 billion in 2026. - The report projects the market will reach $8.76 billion by 2030. - The company released a free sample of the report and the full report online: Download the sample report and View the full report.

The details: - The market grew in part because of limited availability of cancellous sponge materials, dependence on collagen and hydroxyapatite, rising orthopedic surgeries, more awareness of bone grafting techniques and continued use of traditional wound care. - The report cites a 5.9% compound annual growth rate from 2025 to 2026. - The report projects a 5.6% CAGR through 2030. - Future demand is tied to innovations in synthetic and composite cancellous sponges, higher use in dental and plastic surgery, advances in bioactive and regenerative materials, growth of ambulatory surgical centers and more minimally invasive procedures. - Cancellous bone, also called trabecular or spongy bone, has a porous, lattice-like structure. - Cancellous bone is found at the ends of long bones and in the vertebrae, pelvis, ribs and skull. - Compared with cortical bone, cancellous bone is lighter and less compact, which helps keep overall bone weight low. - Cancellous sponges aid bone regeneration and healing in medical treatment. - The report says North America was the largest market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The forecast points to a market moving from traditional material constraints toward more engineered and procedure-specific products. - A projected jump in total joint arthroplasties in the US suggests orthopedic demand could remain a major volume driver. - The American Academy of Orthopedic Surgeons projected in March 2023 that annual primary total joint arthroplasties in the US will rise 70% to about 2,257,326 by 2050. - The same projection puts total hip arthroplasties at 1,219,852 and total knee arthroplasties at 1,037,474 by 2050.

What's next: - The report points to growth opportunities in bone grafting, dental surgery, plastic surgery and ambulatory care settings. - Regional demand will likely depend on local healthcare infrastructure, bone-related disease prevalence and adoption of advanced surgical methods. - The company added market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables to its 2026 reports. - Readers can contact the company for more information at marketing@tbrc.info or by phone using the numbers listed in the release.

The bottom line: - Cancellous sponge demand is rising with orthopedic surgery volumes, and the market outlook points to steady expansion through 2030.